Exact Mass: 422.2780578

Exact Mass Matches: 422.2780578

Found 49 metabolites which its exact mass value is equals to given mass value 422.2780578, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Volicitin

N-(17-hydroxy-9Z,12Z,15Z-octadecatrienoyl) glutamine

C23H38N2O5 (422.2780578)


   

DHAP(O-18:0)

[3-(octadecyloxy)-2-oxopropoxy]phosphonic acid

C21H43O6P (422.27971080000003)


DHAP(O-18:0) is the octadecanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(O-18:0) or 1-Octadecyl-glycerone-3-phosphate is converted from 1-Octadecanoyl-glycerone-3-phosphate via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. (Wikipedia). DHAP(18:0e) is the octadecanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0e) or 1-Octadecyl-glycerone-3-phosphate is converted from 1-Octadecanoyl-glycerone-3-phosphate via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. [HMDB]

   

3-((((-Oxoheptyl)amino)acetyl)amino)methyl-7-oxobicyclo(2.2.1)hept-2-yl-5-heptenoic acid

7-{3-[({1-hydroxy-2-[(1-hydroxyheptylidene)amino]ethylidene}amino)methyl]-7-oxabicyclo[2.2.1]heptan-2-yl}hept-5-enoate

C23H38N2O5 (422.2780578)


   

Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-

N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide

C25H34N4O2 (422.2681624)


   
   
   

20-epi-isoiguesterinol

20-epi-isoiguesterinol

C28H38O3 (422.2820798)


A pentacyclic triterpenoid that is a bisnortriterpene isolated from Salacia madagascariensis and exhibits antileishmanial and antileukemic activities.

   

4-carbamoyl-2-[(9Z,12Z)-(15,16-epoxy)octadeca-9,12-dienoylamino]butyric acid

4-carbamoyl-2-[(9Z,12Z)-(15,16-epoxy)octadeca-9,12-dienoylamino]butyric acid

C23H38N2O5 (422.2780578)


   

dihydrorussulaflavidin

dihydrorussulaflavidin

C28H38O3 (422.2820798)


   
   

5-hydroxy-7-(3,7,11,15-tetramethyl-2,6,10,11-hexadecatetraenyl)-2(3H)-benzofuranone|5-hydroxy-7-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)-2(3H)-benzofuranone

5-hydroxy-7-(3,7,11,15-tetramethyl-2,6,10,11-hexadecatetraenyl)-2(3H)-benzofuranone|5-hydroxy-7-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)-2(3H)-benzofuranone

C28H38O3 (422.2820798)


   

calvasterol A

14alpha-hydroxyergosta-4,7,9,22-tetraen-3,6-dione

C28H38O3 (422.2820798)


   
   
   

homospiculoic acid A

homospiculoic acid A

C28H38O3 (422.2820798)


   

D-NMAPPD

N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-tetradecanamide

C23H38N2O5 (422.2780578)


   

(5Z,7E)-(1S,3R)-22-(3-hydroxyphenyl)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-22-(3-hydroxyphenyl)-23,24,25,26,27-pentanorvitamin D3 / 1α-hydroxy-22-(3-hydroxyphenyl)-23,24,25,26,27-pentanorcholecalciferol

C28H38O3 (422.2820798)


   

(5Z,7E)-(1S,3R)-22-(4-hydroxyphenyl)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-22-(4-hydroxyphenyl)-23,24,25,26,27-pentanorvitamin D3 / 1α-hydroxy-22-(4-hydroxyphenyl)-23,24,25,26,27-pentanorcholecalciferol

C28H38O3 (422.2820798)


   

1-Octadecyl dhap

1-Octadecyl dihdroxyacetone phosphate

C21H43O6P (422.27971080000003)


   

PA(P-18:0/0:0)

1-(1Z-octadecenyl)-glycero-3-phosphate

C21H43O6P (422.27971080000003)


   

LPA O-18:1

1-(9E-octadecyl)-sn-glycero-3-phosphate

C21H43O6P (422.27971080000003)


   

1-stearylglycerone 3-phosphate

1-octadecyl-glycerone 3-phosphate

C21H43O6P (422.27971080000003)


   

ST 28:6;O3

3-oxo-witha-1,4,24-trienolide

C28H38O3 (422.2820798)


   

1alpha-hydroxy-22-(3-hydroxyphenyl)-23,24,25,26,27-pentanorvitamin D3

(5Z,7E)-(1S,3R)-22-(3-hydroxyphenyl)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C28H38O3 (422.2820798)


   

1alpha-hydroxy-22-(4-hydroxyphenyl)-23,24,25,26,27-pentanorvitamin D3

(5Z,7E)-(1S,3R)-22-(4-hydroxyphenyl)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C28H38O3 (422.2820798)


   
   

WAY-100635

Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-

C25H34N4O2 (422.2681624)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists WAY-100635 is a potent and selective 5-HT1A Receptor antagonist with a pIC50 of 8.87, an apparent pA2 of 9.71. WAY-100635 is a potent and selective 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist with an IC50 value of 0.91 nM and Ki value of 0.39 nM. WAY-100635 has pIC50 values for 5-HT1A and α1-adrenergic receptors of 8.9 and 6.6, respectively. WAY-100635 is also a potent dopamine D4 receptor agonist[1][2][3].

   

WAY 100635 Hydrochloride

WAY 100635 Hydrochloride

C25H34N4O2 (422.2681624)


   

(9,9-Dihexyl-9H-fluorene-2,7-diyl)diboronic acid

(9,9-Dihexyl-9H-fluorene-2,7-diyl)diboronic acid

C25H36B2O4 (422.27995560000005)


   

S-[11-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]undecyl] ethanethioate

S-[11-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]undecyl] ethanethioate

C21H42O6S (422.27019520000005)


   

2,3-Bis(2,3-dihydroxypropoxy)propyl laurate

2,3-Bis(2,3-dihydroxypropoxy)propyl laurate

C21H42O8 (422.2879532)


   

4-Butoxyphenyl 4-trans-(4-pentylcyclohexyl)benzoate

4-Butoxyphenyl 4-trans-(4-pentylcyclohexyl)benzoate

C28H38O3 (422.2820798)


   

2-Pyridinecarboxamide, 6-[hexahydro-4-[1-(1-methylethyl)-4-piperidinyl]-1h-1,4-diazepin-1-yl]-n-4-pyridinyl-

2-Pyridinecarboxamide, 6-[hexahydro-4-[1-(1-methylethyl)-4-piperidinyl]-1h-1,4-diazepin-1-yl]-n-4-pyridinyl-

C24H34N6O (422.2793954)


C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist > C107589 - CXCR4 Inhibitor

   

Nandrolone cyclotate

Nandrolone cyclotate

C28H38O3 (422.2820798)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

Minabeolide 1

Minabeolide 1

C28H38O3 (422.2820798)


A withanolide that is (22R)-22,26-epoxyergosta-1,4,24-triene substituted by oxo groups at positions 3 and 26. Isolated from Paraminabea acronocephala, it exhibits antineoplastic and anti-inflammatory activities.

   

(E)-7-[3-[[[2-(heptanoylamino)acetyl]amino]methyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

(E)-7-[3-[[[2-(heptanoylamino)acetyl]amino]methyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid

C23H38N2O5 (422.2780578)


   

N-(17-hydroxylinolenoyl)-L-glutamine

N-(17-hydroxylinolenoyl)-L-glutamine

C23H38N2O5 (422.2780578)


   

1-Oleyl-sn-glycero-3-phosphate

1-Oleyl-sn-glycero-3-phosphate

C21H43O6P (422.27971080000003)


A 1-alkyl-sn-glycerol 3-phosphate in which the alkyl group is specified as oleyl.

   

1-Octadecylglycerone 3-phosphate

1-Octadecylglycerone 3-phosphate

C21H43O6P (422.27971080000003)


A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as octadecyl.

   

1-(9E-octadecyl)-sn-glycero-3-phosphate

1-(9E-octadecyl)-sn-glycero-3-phosphate

C21H43O6P (422.27971080000003)


   

1-(1Z-octadecenyl)-glycero-3-phosphate

1-(1Z-octadecenyl)-glycero-3-phosphate

C21H43O6P (422.27971080000003)


   

1-(1Z-octadecenyl)-sn-glycero-3-phosphate

1-(1Z-octadecenyl)-sn-glycero-3-phosphate

C21H43O6P (422.27971080000003)


A 1-(alk-1-enyl)-sn-glycero-3-phosphate in which the alkenyl group is specified as 1Z-octadecenyl.

   
   

(2s)-2-{[(9z,12z,15z,17r)-1,17-dihydroxyoctadeca-9,12,15-trien-1-ylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

(2s)-2-{[(9z,12z,15z,17r)-1,17-dihydroxyoctadeca-9,12,15-trien-1-ylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

C23H38N2O5 (422.2780578)


   

2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-5,6,7,8a,9,10,12,12a,14,14a-decahydropicene-3,8-dione

2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-5,6,7,8a,9,10,12,12a,14,14a-decahydropicene-3,8-dione

C28H38O3 (422.2820798)


   

(6ar,6br,8ar,11s,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-6a,7,8,9,10,11,12,12a,13,14-decahydropicene-2,6-dione

(6ar,6br,8ar,11s,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-6a,7,8,9,10,11,12,12a,13,14-decahydropicene-2,6-dione

C28H38O3 (422.2820798)


   

(1s,3s,3ar,4r,5s,7ar)-1,3,4,5,7-pentaethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-1,3,4,5,7-pentaethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C28H38O3 (422.2820798)


   

2,3-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-6a,7,8,9,12,12a,13,14-octahydro-6h-picen-5-one

2,3-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-6a,7,8,9,12,12a,13,14-octahydro-6h-picen-5-one

C28H38O3 (422.2820798)